NeuroOne Medical Technologies Corp
NMTC
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.71M
Close$
$-1.04
161.5% downside
Current Fair Value
161.5% downsideOvervalued by 161.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.71 Million |
|---|---|
| Enterprise Value | $12.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.53 |
| Outstanding Shares | 8,436,158 |
Return
| Return on Equity | -123.63% |
|---|---|
| Return on Assets | -84.47% |
| Return on Invested Capital | -112.04% |
Valuation & Multiples
| P/E Ratio | -1.94 |
|---|---|
| PEG | 23.87 |
| Price to Sales | 1.69 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.25 |
| Enterprise Value to EBIT | -1.75 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-0.23
Average shareholder expectationRevenue Estimate
$2.58 M
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.58
Average shareholder expectationRevenue Estimate
$2.55 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 101,500▼ 12.12% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.26%▼ 1.48% |
|---|---|
| Total Invested | $9.14M▼ 3.11% |
| Investors Holding | 32▼ 7.00% |
ESG Score
No data
About NeuroOne Medical Technologies Corp
2,019 employees